Clinical Trials List
2008-06-01 - 2011-07-31
Phase III
Terminated4
ICD-10Z51.11
Encounter for antineoplastic chemotherapy
ICD-9V58.1
Encounter for chemotherapy
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chiun-Sheng Huang Division of General Surgery
- 林璟宏 Division of Hematology & Oncology
- 張金堅 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Wen Chen Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 林明賢 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 馮盈勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24-40 participants
-
Global
600 participants
